4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000030
Chief Medical Officer sold 7,641 shares at an average $40.91 ($312,560)
- Chief Medical Officer acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goncalves Joana · Chief Medical Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,500 | $6.84 | $23,940 | 37,518 | D |
| 2026-03-16 | Exercise or conversion : show line 2 in the form 10b5-1 | +3,500 | $7.80 | $27,300 | 41,018 | D |
| 2026-03-16 | Sale : show line 3 in the form 10b5-1 | −2,921 | $40.11 | $117,159 | 38,097 | D |
| 2026-03-16 | Sale : show line 4 in the form 10b5-1 | −2,902 | $41.20 | $119,569 | 35,195 | D |
| 2026-03-16 | Sale : show line 5 in the form 10b5-1 | −1,177 | $41.94 | $49,359 | 34,018 | D |
| 2026-03-16 | Sale : show line 6 in the form 10b5-1 | −641 | $41.30 | $26,473 | 33,377 | D |
| Open-market sales · 7,641 sh · avg $40.91 · $312,560 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-16 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (right to buy) | −3,500 | 214,563 | D |
| 2026-03-16 | Exercise or conversion : show line 8 in the form 10b5-1 Employee Warrant (right to buy) | −3,500 | 185,992 | D |
Loading xslF345X05/form4.xml…